Mindfulness Based Cognitive Therapy for Bipolar Disorder (MBCT-BD)

April 14, 2023 updated by: Anne Speckens, Radboud University Medical Center
The current study will be a randomized controlled trial (RCT) investigating the clinical and cost-effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) as an adjunct to usual care, versus usual care alone, in reducing depressive symptoms in patients with bipolar disorder. Outcome measures include depressive, (hypo)manic and anxiety symptoms, risk of relapse/recurrence, functioning and mental health/well-being. The study also aims to explore possible working mechanisms such as improvements of mindfulness and self-compassion skills. The study will have a follow-up duration of 15 months from baseline.

Study Overview

Detailed Description

Introduction:

In the Netherlands, the lifetime prevalence of bipolar disorder (BD) is about 1.2% for men and 1.4% for women (de Graaf et al 2010). BD usually manifests itself during late adolescence or early adulthood. Its course is often chronic, with patients suffering from recurrent depressive, (hypo)manic, or mixed episodes, being symptomatic about half of the time (Judd 2002). Although hospital admissions are more common during manic episodes, illness-related disability is more strongly influenced by depressive episodes (Judd 2003). It has been estimated that about 25-50% of the patients with BD attempts suicide at least once and that the risk of suicide is about 5%(Hawton 2005).

Depressive symptoms in BD are common and have been associated with negative effects on the course of bipolar disorder in terms of functional impairment and quality of life (Gutiérrez-Rojas 2008). There are limited data on how to optimize the treatment of persistent or residual depressive symptoms in BD or to improve outcomes for those patients who do not benefit sufficiently from the available treatments. In addition, there is a need for interventions that not only target symptom reduction but also help patients to cope with their illness from a wider perspective, i.e. in terms of their personal values, goals, and social roles.

Mindfulness-Based Cognitive Therapy (MBCT) is an innovative intervention that has been shown effective in reducing depressive symptoms in unipolar recurrent depression (Aalderen 2012, Kuyken 2016) and appears promising for coping with severe mental illness (Davis and Kurzban 2012). Little is known about the effectiveness of MBCT for BD, with a number of pilot studies showing reductions in depressive symptoms, and one RCT showing reduction of anxiety symptoms. Considering the need for additional psychosocial treatments that not only target symptomatic but also personal recovery, these preliminary but encouraging findings warrant a larger RCT examining the efficacy of MBCT for BD in the Netherlands.

Aims:

As there are limited data on how to improve outcomes for those patients who do not benefit sufficiently from the available treatments, this study aims to compare MBCT to TAU as an adjunctive treatment to reduce depressive symptoms in patients with bipolar disorder. Outcomes of MBCT for BD patients will be examined both on a symptom level (depression, mania, anxiety, risk of relapse/recurrence) and in terms of functioning and mental health/well-being, including its possible working mechanisms such as improvements of mindfulness and self-compassion skills.

Method:

A randomized, multicenter, prospective, evaluator-blinded clinical trial of MBCT added to treatment as usual (TAU) versus TAU alone. Assessments will be conducted at baseline and at 3, 6, 9, 12 and 15 months follow-up.

The intervention will consist of usual care, and for half of the participants MBCT will be offered in adjunct. MBCT is a manualised group skills-training program (Segal, Williams & Teasdale 2012) designed as a relapse prevention programme for patients with recurrent depression. The training consists of eight weekly sessions of 2.5 hours, plus one day of silent practice. The program includes both formal and informal meditation exercises. Cognitive techniques that are part of the program are education, monitoring and scheduling of activities, identification of negative automatic thoughts and devising a relapse prevention plan.

The MBCT treatment will based on the 8-week MBCT course developed by Segal, Williams and Teasdale (2012), but will be adapted to address the needs of patients with a bipolar disorder. A few examples of these adaptations are: (more) psychoeducation about manic symptoms in addition to the psychoeducation about depression; introducing the 3-minute breathing space earlier in the programme and more often during sessions, especially when strong emotions are present; repeatedly bringing the focus to self-care; and making use of the mindful movement (yoga) exercises more frequently. All group sessions will be conducted at the respective mental health centres, with each group comprising 8-12 participants. MBCT courses will be taught by experienced and qualified mindfulness teachers, together with a health care professional specialised in the care for BD patients. Teacher competency will be assessed with the Mindfulness-Based Interventions - Teaching Assessment Criteria (Crane et al 2013), for which all trial sessions will be videotaped.

Usual care will consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).

Study Type

Interventional

Enrollment (Actual)

144

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Deventer, Netherlands
        • Dimence GGZ
      • Nijmegen, Netherlands
        • Pro Persona
      • Utrecht, Netherlands
        • Altrecht GGZ
    • Gelderland
      • Nijmegen, Gelderland, Netherlands, 6525 GC
        • Radboud University Nijmegen Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • bipolar I or II disorder
  • having suffered at least two lifetime depressive episodes, either current or in (partial) remission at baseline (according to SCID assessment)
  • Young Mania Rating Scale score < 8

Exclusion Criteria:

  • a manic episode in the 3 months before the start of the trial
  • lifetime diagnosis of schizophrenia or schizoaffective disorder, current substance abuse disorder, organic brain syndrome, antisocial or borderline personality disorder
  • risk of suicide or aggression
  • the presence of a concurrent significant medical condition impeding the ability to participate
  • currently receiving regular psychological therapy
  • previous participation in a MBCT or MBSR course

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness Based Cognitive Therapy added to usual care
Patients in the MBCT arm will be invited to participate in MBCT added to their usual care.

MBCT is a manualised group skills-training program (Segal, Williams & Teasdale 2012) consisting of eight weekly sessions of 2.5 hours, plus one day of silent practice. The program includes both formal and informal meditation exercises. Cognitive techniques that are part of the program are education, monitoring and scheduling of activities, identification of negative automatic thoughts and devising a relapse prevention plan.

The MBCT treatment will be adapted to address the needs of patients with a bipolar disorder. A few examples of these adaptations are: (more) psychoeducation about manic symptoms in addition to the psychoeduction about depression; introducing the 3-minute breathing space earlier in the programme and more often during sessions, especially when strong emotions are present; repeatedly bringing the focus to self-care; and making use of the mindful movement (yoga) exercises more frequently.

Other Names:
  • MBCT
  • Mindfulness training
Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse). Usual care will not be restricted, except for proscribing high-frequency psychological interventions such as (group) cognitive behavioral therapy, for practical and methodological reasons.
Active Comparator: Usual Care
Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).
Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse). Usual care will not be restricted, except for proscribing high-frequency psychological interventions such as (group) cognitive behavioral therapy, for practical and methodological reasons.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inventory of Depressive Symptomatology
Time Frame: Change between baseline and 3 months
A clinican-administered interview assessing the severity of depressive symptoms
Change between baseline and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Structured Clinical Interview for DSM-IV-TR Disorders
Time Frame: Change between baseline and 15 months
Diagnostic instrument to assess relapse of depressive or (hypo)manic episode
Change between baseline and 15 months
Young Mania Rating Scale
Time Frame: Change between baseline and 3 months
Young Mania Rating Scale (YMRS) Dutch translation. The YMRS is an 11-item clinician-administered rating scale to assess the severity of (hypo)manic symptoms. It was found to be a reliable, valid, and sensitive rating scale to measure the severity of mania (Young et al., 1978). Its total score ranges from 0 (no (hypo)manic symptoms) to 44 (severe manic symptoms).
Change between baseline and 3 months
Young Mania Rating Scale
Time Frame: Change between baseline and 15 months
Young Mania Rating Scale (YMRS) Dutch translation. The YMRS is an 11-item clinician-administered rating scale to assess the severity of (hypo)manic symptoms. It was found to be a reliable, valid, and sensitive rating scale to measure the severity of mania (Young et al., 1978). Its total score ranges from 0 (no (hypo)manic symptoms) to 44 (severe manic symptoms).
Change between baseline and 15 months
Functioning Assessment Short Test
Time Frame: Change between baseline and 3 months
Brief instrument designed to assess the main functioning problems experienced by psychiatric patients, particularly bipolar patients
Change between baseline and 3 months
Functioning Assessment Short Test
Time Frame: Change between baseline and 15 months
Brief instrument designed to assess the main functioning problems experienced by psychiatric patients, particularly bipolar patients
Change between baseline and 15 months
State/Trait Anxiety Inventory
Time Frame: Change between baseline and 3 months
self-report measure for assessing both state and trait levels of anxiety
Change between baseline and 3 months
State/Trait Anxiety Inventory
Time Frame: Change between baseline and 15 months
self-report measure for assessing both state and trait levels of anxiety
Change between baseline and 15 months
Ruminative Response Scale - brooding subscale
Time Frame: Change between baseline and 3 months
Brooding subscale of the extended version of the Ruminative Response Scale (RRS-EXT). The authors reported adequate internal consistency (α = .79) and test-retest stability (α = .62, with a one year time interval) for the brooding subscale, which consists of five items. We select the brooding subscale because over time, brooding, or rumination, has been more strongly related to levels of depression (Treynor et al., 2003). Items are scored between 1 ((almost) never) to 4 ((almost) always and subscale score ranges between 5 and 20. A higher score indicates a higher level of ruminative brooding.
Change between baseline and 3 months
Ruminative Response Scale - brooding subscale
Time Frame: Change between baseline and 15 months
Brooding subscale of the extended version of the Ruminative Response Scale (RRS-EXT). The authors reported adequate internal consistency (α = .79) and test-retest stability (α = .62, with a one year time interval) for the brooding subscale, which consists of five items. We select the brooding subscale because over time, brooding, or rumination, has been more strongly related to levels of depression (Treynor et al., 2003). Items are scored between 1 ((almost) never) to 4 ((almost) always and subscale score ranges between 5 and 20. A higher score indicates a higher level of ruminative brooding.
Change between baseline and 15 months
Five Facet Mindfulness Questionnaire, short form
Time Frame: Change between baseline and 3 months
Self-report measure consisting of 24 items divided into the subscales observing, describing, acting with awareness, non-judging and non-reactivity.
Change between baseline and 3 months
Five Facet Mindfulness Questionnaire, short form
Time Frame: Change between baseline and 15 months
Self-report measure consisting of 24 items divided into the subscales observing, describing, acting with awareness, non-judging and non-reactivity.
Change between baseline and 15 months
Self-Compassion Scale
Time Frame: Change between baseline and 3 months
Self-Compassion Scale - short form (SCS-SF). The present study will use the 12-item Dutch short-form version of the SCS-SF to measure self-compassion. The scale consists of six components, including self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification. The SCS-SF has good reliability and validity (Raes et al., 2011). In the short form, each scale consists of 2 items scored between 1 ((almost) never) to 7 ((almost) always) and subscale score ranges between 2 and 14. A higher score indicates a higher level of self-kindness, common humanity, and mindfulness, and lower scores of self-judgment, isolation, and over-identification. Total scores range from 12 to 84 (summed subscale scores), a higher score indicates a higher level of selfcompassion.
Change between baseline and 3 months
Self-Compassion Scale
Time Frame: Change between baseline and 15 months
Self-Compassion Scale - short form (SCS-SF). The present study will use the 12-item Dutch short-form version of the SCS-SF to measure self-compassion. The scale consists of six components, including self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification. The SCS-SF has good reliability and validity (Raes et al., 2011). In the short form, each scale consists of 2 items scored between 1 ((almost) never) to 7 ((almost) always) and subscale score ranges between 2 and 14. A higher score indicates a higher level of self-kindness, common humanity, and mindfulness, and lower scores of self-judgment, isolation, and over-identification. Total scores range from 12 to 84 (summed subscale scores), a higher score indicates a higher level of selfcompassion.
Change between baseline and 15 months
Mental Health Continuum - short form
Time Frame: Change between baseline and 3 months
A 14-item self-report questionnaire that assesses emotional, psychological and social well-being
Change between baseline and 3 months
Mental Health Continuum - short form
Time Frame: Change between baseline and 15 months
A 14-item self-report questionnaire that assesses emotional, psychological and social well-being
Change between baseline and 15 months
Inventory of Depressive Symptomatology
Time Frame: 6 months
A clinican-administered interview assessing the severity of depressive symptoms
6 months
Inventory of Depressive Symptomatology
Time Frame: 9 months
A clinican-administered interview assessing the severity of depressive symptoms
9 months
Inventory of Depressive Symptomatology
Time Frame: 12 months
A clinican-administered interview assessing the severity of depressive symptoms
12 months
Inventory of Depressive Symptomatology
Time Frame: 15 months
A clinican-administered interview assessing the severity of depressive symptoms
15 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Euro-Quality of Life 5D-5L
Time Frame: baseline
Short self-report instrument to assess quality adjusted life years
baseline
Euro-Quality of Life 5D-5L
Time Frame: 3 months
Short self-report instrument to assess quality adjusted life years
3 months
Euro-Quality of Life 5D-5L
Time Frame: 6 months
Short self-report instrument to assess quality adjusted life years
6 months
Euro-Quality of Life 5D-5L
Time Frame: 9 months
Short self-report instrument to assess quality adjusted life years
9 months
Euro-Quality of Life 5D-5L
Time Frame: 12 months
Short self-report instrument to assess quality adjusted life years
12 months
Euro-Quality of Life 5D-5L
Time Frame: 15 months
Short self-report instrument to assess quality adjusted life years
15 months
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: baseline
Health service receipt interview designed for economic evaluations in the Netherlands
baseline
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 3 months
Health service receipt interview designed for economic evaluations in the Netherlands
3 months
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 6 months
Health service receipt interview designed for economic evaluations in the Netherlands
6 months
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 9 months
Health service receipt interview designed for economic evaluations in the Netherlands
9 months
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 12 months
Health service receipt interview designed for economic evaluations in the Netherlands
12 months
Trimbos/iMTA Questionnaire on Costs associated with Psychiatric illness
Time Frame: 15 months
Health service receipt interview designed for economic evaluations in the Netherlands
15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne Speckens, Prof., Radboud University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 23, 2018

Primary Completion (Actual)

June 16, 2020

Study Completion (Actual)

June 17, 2021

Study Registration Dates

First Submitted

September 18, 2017

First Submitted That Met QC Criteria

April 24, 2018

First Posted (Actual)

April 25, 2018

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 14, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The authors intend to make the data available to other researchers after completion of the study and will comply with open access procedures, including open access publishing, as much as possible.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bipolar Disorder

Clinical Trials on Mindfulness Based Cognitive Therapy

3
Subscribe